Date(s) And Time(s):
May 10 2011 8:00AM - May 11 2011 4:00PM
Tower Hall Funabori
The fourth annual conference for Asian new drug development was held in Tokyo in April, 2010. Several issues about Asian development were discussed
intensively from the sponsor’s and the regulatory reviewer’s point of view.
For the fifth conference, the program committee has been joined by colleagues from East Asian countries – China, the Republic of Korea,
Chinese Taipei, and Japan – who are actively involved in drug development in Asia. Nowadays, the practical organizations for Asian collaboration have
been set up and several fruitful outcomes have been published. The more critical topics have been selected.
Main topics are as follows:
3) Safety Reporting, Pharmacovigilance
4) GCP Compliance and Inspection
Several experts in drug development from China, the Republic of Korea, Chinese Taipei, and Japan will share their experiences and discuss how we
can contribute to healthcare and the patients in Asia. We are also planning for opportunities for substantive discussion with Asian regulators including
PMDA in order to develop new drugs which contribute to public health.
This program will benefit the following individuals
• Clinical development professionals
• Personnel involved in regulatory affairs
• Personnel at clinical study sites
• Personnel at CROs and SMOs
tel +81-3-5833-8444 • fax +81-3-5820-8448